AI Uncovered
Welcome to AI Uncovered, a podcast for technology enthusiasts that explores the intersection of generative AI, machine learning, and innovation across regulated industries. With the AI software market projected to reach $14 trillion by 2030, each episode features compelling conversations with an innovator exploring the impact of generative AI, LLMs, and other rapidly evolving technologies across their organization. Hosted by Executive VP of Product at Yseop, Tim Martin leads a global team and uses his expertise to manage the wonderful world of product.
- Update frequency
- every 46 days
- Average duration
- 32 minutes
- Episodes
- 15
- Years Active
- 2023 - 2025
Karla Childers - Ethical Guardrails for AI in Pharma
We welcome Karla Childers to AI Uncovered. Karla is a long-standing leader in bioethics and data transparency in the pharmaceutical industry. As part of the Office of the Chief Medical Officer at Joh…
Oeystein Kjoersvik - Auditing AI: Quality, Compliance & the Role of GenAI in Pharma
We’re excited to welcome Oeystein Kjoersvik to AI Uncovered. Oeystein leads the Generative AI program within the Quality Assurance team at Merck, where he focuses on developing AI tools and applying …
Emmanuel Walckenaer: AI’s Real-World Impact on Pharma & What’s Next in 2025
We’re thrilled to welcome Emmanuel Walckenaer, CEO of Yseop, back to AI Uncovered for a follow-up conversation on the rapid evolution of AI in biopharma. Since his last appearance, the industry has …
Meredith Brown-Tuttle: AI’s Impact on Global Regulatory Strategy and the Future of Pharma
We welcome Meredith Brown-Tuttle to AI Uncovered. Meredith is the Chief Regulatory Strategist at Regulatorium, where she applies her 33 years of experience in the pharmaceutical and biologics indust…
Michael Penlington - Impact of AI and New Standards in Clinical Trials
We welcome Michael Penlington to AI Uncovered. Michael has been working in Pharma for his entire career including roles in leading development of Vaccines and Clinical reporting at Novartis, as well …
Rohit Sood - Digital Transformation & AI's Role in Life Sciences
We welcome Rohit Sood to AI Uncovered. Rohit is a seasoned executive with a strong background in commercialization and technology use in life sciences. He currently advises a variety of life science …
Fred Schonenberg - The Vital Role of GenAI in Enterprises
We welcome Fred Schonenberg to AI Uncovered. Fred is the founder and CEO of VentureFuel. He has created an innovation framework that bridges the VC, Angel, and Startup ecosystem with enterprises to d…
Sarah Tilly - AI in Medical Writing
Welcome Sarah Tilly to AI Uncovered. Sarah is the Founder and Director of Azur Health Science, a regulatory writing consultancy based in France.
Guided by her expertise as a member of the European Med…
Derek Kerton - AI’s Impact on Automobiles
We welcome Derek Kerton to AI Uncovered. Derek is the Founder and Chairman of the Autotech Council in Silicon Valley. His work brings global car companies together with startups to drive discussion a…
Daniel O'Mahony - BioPharma 4.0 & The Role of AI in Drug Manufacturing
We welcome Daniel O'Mahony to AI Uncovered. Daniel is a senior manager of sales and business consulting with Körber Pharma, a pharma manufacturing software company. Along with his work at Körber, Dan…
Gregor Mittersinker - "AI, ChatGPT, and the Impact on UX & Design"
We welcome Gregor Mittersinker to AI Uncovered. Gregor is the founder and creative director at Loft. Loft focuses on product development and design with a specialty in building large product ecosyste…
Marjo Gazak - "What used to take 8 hours, I can now generate a first draft in 1 second"
We welcome Marjo Gazak to AI Uncovered. Marjo is a life sciences expert with over 22 years of experience in drug development, regulatory submissions, document development innovation and data mining s…
Emmanuel Walckenaer - "In the next five years, 80% of the life sciences industry will be using this type of AI"
The second episode features a conversation with Emmanuel Walckenaer, CEO of Yseop. Yseop is reimagining the future of scientific writing through generative AI. The company's mission is to get medicin…
Craig Vachon - “I still think ChatGPT is kind of a gimmick”
The first episode features a conversation with Craig Vachon, CEO of AI Redefined (AIR) and Head of US Operations at NextStage AM. Craig is an angel investor, author, TED speaker, and chairman of Yseo…
Welcome to AI Uncovered!
Welcome to AI Uncovered, a podcast for technology enthusiasts that explores the intersection of generative AI, machine learning, and innovation across regulated industries.
With the AI software marke…